Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum-Reference-Cited by-同舟云学术

Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum

Published:1986-05 Issue:3 Volume:23 Page:292-296
ISSN:0004-5632
Container-title:Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
language:en
Short-container-title:Ann Clin Biochem

Author:

Shelley M D¹,Fish R G¹

Affiliation:

1. Department of Biochemistry, South Wales Radiotherapy and Oncology Service, Velindre Hospital, Whitchurch, Cardiff, South Glamorgan, Wales, UK

Abstract

An immunoradiometric assay, that uses a monoclonal antibody attached to a solid support and developed for the detection of the ovarian tumour antigen, CA125, in serum, has been evaluated. The method was simple to perform, with reagents having a shelf-life of approximately 4 weeks. The potentials and limitations of this test are discussed.

Publisher

SAGE Publications

Subject

Clinical Biochemistry,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/000456328602300308

Reference19 articles.

1. Epithelial Carcinoma of the Ovary: Current Strategies

2. RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA

3. Biochemical Markers in Ovarian Cancer: Possibilities and Limitations

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OC125 immunoscintigraphy in ovarian carcinoma: A comparison with alternative methods of assessment;Clinical Oncology;1990-07

2. CA125 in ovarian tumour tissue at second laparotomy;British Journal of Cancer;1989-02

3. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary;Gynecologic Oncology;1988-07

4. The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy;European Journal of Cancer and Clinical Oncology;1987-06